Global Hypertriglyceridemia Therapeutics Market- Regional Analysis
Among region, North America is estimated to hold a dominant position in the global hypertriglyceridemia therapeutics market over the forecast period owing to the increase prevalence of CVD such as coronary artery disease and atherosclerosis. For instance, on May 15, 2023, according to the CDC in U.S, coronary heart disease (CHD) is the most common type of heart disease, affecting about 375,476 people in 2021. About 1 in 20 adults age 20 and older have CAD (about 5%) and about 2 in 10 deaths from CAD happen in adults less than 65 years old.
Hypertriglyceridemia Therapeutics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients